Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
Condition(s) studied
Investigational drug(s) / intervention(s)
No intervention will be given to patients.: Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.
Study summary
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
Eligibility
Primary outcome measure(s)
- Confirmation of diagnosis by pathologist — Up to 3 years
Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University | Wuhan | Hubei | Recruiting |
More Renmin Hospital of Wuhan University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03972956 on ClinicalTrials.gov ↗ ← All trials in China